Richard Newitter
Stock Analyst at Truist Securities
(3.93)
# 573
Out of 5,149 analysts
455
Total ratings
49.27%
Success rate
10.64%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $47 → $30 | $26.26 | +14.24% | 17 | Mar 2, 2026 | |
| KIDS OrthoPediatrics | Maintains: Hold | $19 → $20 | $18.67 | +7.12% | 11 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $82 → $89 | $78.84 | +12.89% | 23 | Mar 2, 2026 | |
| SIBN SI-BONE | Reiterates: Buy | $23 → $24 | $15.34 | +56.45% | 2 | Feb 24, 2026 | |
| IRTC iRhythm Holdings | Reiterates: Buy | $215 → $200 | $125.85 | +58.92% | 20 | Feb 23, 2026 | |
| TNDM Tandem Diabetes Care | Reiterates: Hold | $24 → $27 | $23.74 | +13.73% | 5 | Feb 23, 2026 | |
| ITGR Integer Holdings | Maintains: Buy | $95 → $97 | $86.75 | +11.82% | 13 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $390 → $360 | $241.84 | +48.86% | 5 | Feb 19, 2026 | |
| DXCM DexCom | Reiterates: Buy | $82 → $80 | $73.08 | +9.47% | 4 | Feb 17, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $96 → $70 | $65.80 | +6.38% | 31 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $85.28 | +4.36% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $95 | $73.85 | +28.64% | 21 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $25 | $11.57 | +116.08% | 6 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $340.16 | +9.95% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $34.39 | +30.85% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.57 | +91.08% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $400 → $392 | $384.59 | +1.93% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $96.71 | +10.64% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $497.42 | +30.67% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $117.75 | +23.14% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $91.70 | +14.50% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $13.21 | +51.40% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.56 | +42.05% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $122.19 | +12.12% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $97.97 | +15.34% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.62 | +162.47% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $83.08 | -1.30% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $174.21 | +43.50% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.87 | +805.92% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $182.64 | +321.59% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.46 | +12.64% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.05 | +65.98% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $29.83 | -9.49% | 5 | Feb 23, 2021 |
PROCEPT BioRobotics
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $26.26
Upside: +14.24%
OrthoPediatrics
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $18.67
Upside: +7.12%
Lantheus Holdings
Mar 2, 2026
Maintains: Buy
Price Target: $82 → $89
Current: $78.84
Upside: +12.89%
SI-BONE
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $15.34
Upside: +56.45%
iRhythm Holdings
Feb 23, 2026
Reiterates: Buy
Price Target: $215 → $200
Current: $125.85
Upside: +58.92%
Tandem Diabetes Care
Feb 23, 2026
Reiterates: Hold
Price Target: $24 → $27
Current: $23.74
Upside: +13.73%
Integer Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $86.75
Upside: +11.82%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $390 → $360
Current: $241.84
Upside: +48.86%
DexCom
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $73.08
Upside: +9.47%
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $96 → $70
Current: $65.80
Upside: +6.38%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $85.28
Upside: +4.36%
Feb 5, 2026
Maintains: Buy
Price Target: $120 → $95
Current: $73.85
Upside: +28.64%
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $11.57
Upside: +116.08%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $340.16
Upside: +9.95%
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $34.39
Upside: +30.85%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.57
Upside: +91.08%
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $384.59
Upside: +1.93%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $96.71
Upside: +10.64%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $497.42
Upside: +30.67%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $117.75
Upside: +23.14%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $91.70
Upside: +14.50%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $13.21
Upside: +51.40%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.56
Upside: +42.05%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $122.19
Upside: +12.12%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $97.97
Upside: +15.34%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.62
Upside: +162.47%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $83.08
Upside: -1.30%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $174.21
Upside: +43.50%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.87
Upside: +805.92%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $182.64
Upside: +321.59%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.46
Upside: +12.64%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.05
Upside: +65.98%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $29.83
Upside: -9.49%